Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,587 | 94 | 98.2% |
| Education | $28.77 | 2 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $293.08 | 18 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $285.22 | 18 | $0 (2024) |
| Dermavant Sciences, Inc. | $164.19 | 11 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $147.58 | 9 | $0 (2024) |
| Lilly USA, LLC | $119.70 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $89.99 | 6 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $78.73 | 5 | $0 (2024) |
| Galderma Laboratories, L.P. | $69.09 | 4 | $0 (2024) |
| Incyte Corporation | $60.00 | 3 | $0 (2024) |
| AbbVie Inc. | $47.91 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $580.82 | 35 | Regeneron Healthcare Solutions, Inc. ($170.70) |
| 2023 | $677.70 | 37 | Amgen Inc. ($117.63) |
| 2022 | $154.86 | 10 | Amgen Inc. ($60.61) |
| 2021 | $113.38 | 7 | Amgen Inc. ($44.52) |
| 2020 | $72.38 | 5 | Sun Pharmaceutical Industries Inc. ($26.47) |
| 2018 | $3.20 | 1 | Pierre Fabre Pharmaceuticals, Inc. ($3.20) |
| 2017 | $13.50 | 1 | Galderma Laboratories, L.P. ($13.50) |
All Payment Transactions
96 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/14/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Immunology | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $19.01 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Inflammation | ||||||
| 10/09/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Inflammation & Immunology | ||||||
| 09/19/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: DERMATOLOGY | ||||||
| 09/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.82 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Inflammation | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Immunology | ||||||
| 08/08/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.45 | General |
| 07/25/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Inflammation | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/11/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Immunology | ||||||
| 06/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: DERMATOLOGY | ||||||
| 06/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 05/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Immunology | ||||||
| 05/23/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.27 | General |
| 05/16/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Immunology | ||||||
| 05/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/25/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $16.03 | General |
| Category: Dermatology | ||||||
| 04/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Immunology | ||||||
| 04/03/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,268 | 1,814 | $316,324 | $149,142 |
| 2022 | 18 | 1,209 | 1,727 | $298,388 | $153,493 |
| 2021 | 15 | 1,134 | 1,540 | $212,326 | $136,480 |
| 2020 | 11 | 922 | 1,152 | $141,495 | $81,899 |
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 419 | $89,777 | $43,155 | 48.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 315 | $47,809 | $22,497 | 47.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 202 | 244 | $43,608 | $21,112 | 48.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 138 | 268 | $23,591 | $12,204 | 51.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $24,187 | $11,386 | 47.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 16 | 18 | $21,200 | $9,775 | 46.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 72 | 92 | $10,710 | $5,128 | 47.9% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 16 | 18 | $13,262 | $5,118 | 38.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 99 | 110 | $10,555 | $5,109 | 48.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 46 | 47 | $10,391 | $5,093 | 49.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $8,484 | $3,943 | 46.5% |
| 11106 | Incision biopsy, first skin growth | Office | 2023 | 13 | 13 | $3,566 | $1,720 | 48.2% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 13 | $5,516 | $1,444 | 26.2% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 14 | $2,359 | $792.68 | 33.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 36 | 111 | $1,308 | $664.91 | 50.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 344 | $62,304 | $34,336 | 55.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 222 | 318 | $43,887 | $23,079 | 52.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 181 | 230 | $39,009 | $20,730 | 53.1% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 21 | 25 | $28,257 | $14,111 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 74 | 74 | $17,907 | $9,629 | 53.8% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 112 | 207 | $18,446 | $9,542 | 51.7% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 21 | 22 | $15,562 | $7,929 | 50.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 87 | 111 | $13,203 | $6,501 | 49.2% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2022 | 13 | 13 | $7,918 | $4,304 | 54.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 32 | 32 | $6,884 | $3,848 | 55.9% |
About Dr. Jeffrey Whitworth, M.D
Dr. Jeffrey Whitworth, M.D is a MOHS-Micrographic Surgery healthcare provider based in West Paterson, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144269440.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Whitworth, M.D has received a total of $1,616 in payments from pharmaceutical and medical device companies, with $580.82 received in 2024. These payments were reported across 96 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,587).
As a Medicare-enrolled provider, Whitworth has provided services to 4,533 Medicare beneficiaries, totaling 6,233 services with total Medicare billing of $521,014. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Practice Information
- Specialty MOHS-Micrographic Surgery
- Location West Paterson, NJ
- Active Since 06/05/2006
- Last Updated 07/30/2010
- Taxonomy Code 207ND0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1144269440
Products in Payments
- DUPIXENT (Biological) $306.70
- Otezla (Drug) $293.08
- VTAMA (Drug) $164.19
- Sotyktu (Drug) $147.58
- TALTZ (Drug) $101.30
- Winlevi (Drug) $63.52
- OPZELURA (Drug) $60.00
- TREMFYA (Drug) $32.73
- CIBINQO (Drug) $32.54
- SKYRIZI (Biological) $31.10
- LEVULAN KERASTICK (Drug) $26.47
- APEXICON E (Drug) $20.00
- EBGLYSS (Drug) $18.40
- Cimzia (Drug) $17.23
- RINVOQ (Biological) $16.81
- JUBLIA (Drug) $16.26
- Zoryve (Drug) $15.23
- Erivedge (Biological) $15.17
- AMELUZ (Drug) $15.00
- DUOBRII (Drug) $14.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.